This disruption leads to a boost in eosinophils in the lungs. Eosinophils are immune cells that hinder the function of other cells responsible for clearing pathogens from the lungs. In a mouse model ...

Discover the impact of hypereosinophilia on heart health, focusing on eosinophilic heart disease (EHD) and its mechanisms.

This is largely due to more than 90% of patients with AIN having no signs or symptoms, and the fact that individual ...

One of three patients in Cohort 5 achieved complete histological remission at 12 weeks. <li /> Consistent improve ...

Researchers from Johns Hopkins Medicine and Yale University have collaborated on the development and application of a ...

The data show: One patient achieved complete histological remission, defined by the presence of fewer than six eosinophils per high-powered field on esophageal biopsy. Straumann Dysphagia Index, a ...

Amali Samarasinghe, PhD, associate professor in the Department of Pediatrics at UT Health Science Center, describes herself as an aficionada of the alternative hypothesis. “I have a passion to uncover ...

Dubai: The first biological treatment for chronic obstructive pulmonary disease (COPD), now available in the UAE, offers new ...

The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...

Research and development expenses were $15.4 million for the quarter ended September 30, 2024, compared to $7.8 million for the same period in 2023. The increase of $7.6 million was primarily driven ...

Paris: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic ...

EMA approves Dupixent to treat eosinophilic esophagitis in children as young as one year: Paris Thursday, November 7, 2024, 14:00 Hrs [IST] The European Medicines Agency has appro ...